← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2022-10-25

Drug application

FDA Application #

ANDA215595

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL RX

Manufacturer

Chartwell RX, LLC

First approval

2022-10-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown